{"id":"W4413092759","doi":"10.1016/j.annonc.2025.05.190","title":"177P Association of alpha-fetoprotein (AFP) and clinical outcomes in patients with unresectable hepatocellular carcinoma (uHCC) treated with camrelizumab + rivoceranib vs sorafenib (CARES-310)","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sorafenib; Hepatocellular carcinoma; Internal medicine; Oncology; Alpha-fetoprotein; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003198613,0.0001613786,0.0004295715,0.000197523,0.0001853347,0.0004897059,0.0001963101,0.0003433548,0.001851508],"category_scores_gemma":[0.001052219,0.0001213925,0.0008511969,0.0003432411,0.0001980603,0.0003776383,0.0002531672,0.0006372811,0.0002064506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003761621,"about_ca_system_score_gemma":0.0003724206,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001430444,"about_ca_topic_score_gemma":0.001994207,"domain_scores_codex":[0.9997869,0.00004872869,0.00002081354,0.00004489131,0.00003186359,0.00006682766],"domain_scores_gemma":[0.9995216,0.0001157286,0.0001406347,0.00002334698,0.00003363781,0.0001650954],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.0269139,0.0002766957,0.9477065,0.00007361596,0.0009744437,0.0003090717,0.00006334,0.0005246837,0.002542009,0.0001352166,0.001228924,0.01925151],"study_design_scores_gemma":[0.0008522685,0.004525015,0.989806,0.00002217728,0.0009131725,0.0006093872,0.0001596642,0.001109225,0.0005454872,0.0002798349,0.001155133,0.00002259085],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982612,0.0007419012,0.00003507365,0.0001331677,0.00004485214,0.000003848306,0.0002109024,0.0000038467,0.0005653002],"genre_scores_gemma":[0.9992408,0.000118472,0.00002314971,0.00005565686,0.00004023928,0.000003823615,0.0002964166,0.0000011032,0.0002204095],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001851508,"threshold_uncertainty_score":0.006193876,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04966078919795928,"score_gpt":0.3210906622515927,"score_spread":0.2714298730536334,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}